MedPath

Efficacy of acupuncture in the treatment of acute idiopathic hearing loss with tinnitus: a randomized,double blind control pilot study

Phase 4
Recruiting
Conditions
H93.1
H91.2
Tinnitus
Sudden idiopathic hearing loss
Registration Number
DRKS00012664
Lead Sponsor
HNO Klinik Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Acute idiopathic hearing loss with tinnitus
- Written declaration of consent
- Knowledge of the German language
- Age at least 18 years
- initial, planned or ongoing, therapy with cortisone according to the standard of the ENT clinic Heidelberg

Exclusion Criteria

- Chronic recurrent hearing loss
- Chronic tinnitus
- Known coagulopathy or anticoagulant therapy with bleeding time over 4 minutes, thrombocytes <50,000 / µl
- Lack of compliance
- Acute disease in the acupuncture area, which do not allow acupuncture
- Acute neuropsychiatric disorders
- analgesic, opioid or drug dependence
- Inability to follow the instructions in the study (lack of language, dementia)
- Participate in another clinical trial
- Continuous pension-related compensation or opposition proceedings
- Specific immunotherapy (in treatment)
- pregnancy
- Malignomas in the anamnesis
- Cortisone therapy before the beginning of the study (due to other diseases)
- nickel allergy
- silicone allergy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the subjectively perceived overall impairment by the symptoms of tinnitus and hearing loss by means of the visual analogue scale (VAS).<br>Test are performed:<br>at initial presentation, after 14 days of therapy with Prednisolone (2 weeks after initial presentation), after acupuncture (4 weeks after initial presentation), at time of follow-up examination 8 weeks after initial presentation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath